cloudy
Saturday November 18th, 2017 8:59AM
9:48PM ( 11 hours ago ) Weather Alert

FDA advisers endorse what could be 1st US gene therapy

By The Associated Press
Related Articles
  Contact Editor

A panel of cancer experts Wednesday recommended approval of what could become the first gene therapy available in the U.S.

The Food and Drug Administration advisory panel voted 10-0 in favor of an advanced leukemia treatment developed by the University of Pennsylvania and Novartis Corp. The FDA usually follows recommendations of its expert panels, but isn't obligated to do so.

The therapy could be the first of a wave of treatments custom-made to target a patient's cancer. Called CAR-T, it involves removing immune cells from a patients' blood, reprogramming them to create an army of cells that can zero in on and destroy cancer cells, and injecting them back into the patient.

"This is a major advance," said panel member Dr. Malcolm A. Smith of the National Cancer Institute. He said the treatment is "ushering in a new era."

The vote came after lengthy discussion and impassioned pleas from the fathers of two young patients whose lives were saved by the therapy. The one-time leukemia treatment would be for children and young adults with the most common form of childhood cancer, known as ALL.

"Our daughter was going to die and now she leads a normal life," said Tom Whitehead, of Philipsburg, Pennsylvania. His daughter Emily, now 12, was the first child to receive the experimental therapy, five years ago. "We believe when this treatment is approved, it will save thousands of children's lives around the world."

After decades of setbacks and disappointments in efforts to fix, replace, or change genes to cure diseases, several companies are near the finish line in a race to bring CAR-T and other types of gene therapy to patients. Kite Pharma also has a CAR-T therapy in FDA review and Juno Therapeutics and others are in late stages of testing.

Novartis is seeking approval to use the treatment for patients aged 3 to 25 with a blood cancer called acute lymphoblastic leukemia whose disease has spread or failed to respond to standard treatment. That happens to more than 600 patients in the U.S. each year. At that point, they have limited options — all more toxic than the CAR-T therapy — and survival chances are slim. ALL accounts for a quarter of all cancers in children under age 15.

In a key test, results were far better than chemotherapy and even newer types of cancer drugs. Of the 52 patients whose results were analyzed, 83 percent had complete remission, meaning their cancer vanished. Most patients suffered serious side effects but nearly all recovered.

CAR-T therapy starts with filtering key immune cells called T cells from a patient's blood. In a lab, a gene is then inserted into the T cells that prompts them to grow a receptor that targets a special marker found on some blood cancers. Millions of copies of the new T cells are grown in the lab and then injected into the patient's bloodstream where they can seek out and destroy cancer cells. Doctors call it a "living drug" — permanently altered cells that continue to multiply in the body into an army to fight the disease.

During the patient testing, the whole process took about 16 weeks, which can be too long a wait for some desperately ill patients, the FDA advisers noted during the meeting in Silver Spring, Maryland. Drug company officials said they can now produce a treatment and get it to a patient in about three weeks.

Novartis said in a statement that it has long believed CAR-T therapy could "change the cancer treatment paradigm."

The cost of CAR-T therapy is likely to be hundreds of thousands of dollars, but it's only given once. Typically, cancer patients take one or more drugs until they stop working, then switch to other drugs, so treatment — and side effects — can go on for years.

The treatment's short-term side effects, including fever and hallucinations, are often intense as the body's revved up immune system goes on the attack. The long-term side effects of the treatment are unknown. It's also unclear if patients whose cancer goes into remission will be cured or will have their cancer return eventually. The FDA panel recommended that patients who get the treatment be monitored for 15 years.

Other biotech and pharmaceutical companies are developing types of gene therapy to treat solid cancers and rare gene-linked diseases. A few products have been approved elsewhere — one for head and neck cancer in China in 2004 and two in Europe, most recently GlaxoSmithKline's Strimvelis. That was approved last year for a deadly condition called severe combined immunodeficiency and launched with a $670,000 price tag.

UniQure's Glybera was approved for a rare enzyme disorder. It was used only once in five years, likely due to its $1 million-plus price tag, so uniQure is pulling it from the market.

___

Follow Linda A. Johnson at https://twitter.com/LindaJ_onPharma

  • Associated Categories: Associated Press (AP), AP National News, AP Health, AP Health - Children's Health, AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2017 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Trump in Paris: The curious case of his friend Jim
When President Donald Trump takes his first official trip to Paris Thursday, it's unlikely that his enigmatic friend Jim will tag along
5:04PM ( 2 minutes ago )
Where's Rey? Despite Monopoly maker's promise, still missing
The Rey character from the "Star Wars" version of Monopoly apparently is in a land far, far away
4:57PM ( 9 minutes ago )
Brittany Lang needs better to defend in US Women's Open
The U.S. Women's Open has not had a repeat winner since Karrie Webb in 2001 and the chances of Brittany Lang doing it this year don't seem good
4:57PM ( 9 minutes ago )
Associated Press (AP)
Yellen says Fed watching slowdown in inflation
Yellen to Congress: Recent inflation slowdown could lead Fed to rethink pace of rate hikes
4:38PM ( 28 minutes ago )
The Latest: Schiff _ House intel wants look at online 'bots'
The top Democrat on the House Intelligence committee says his panel wants to look at the use of Russian social media "trolls" or "bots" and whether they are connected to President Donald Trump's campaign or its digital strategy.
4:35PM ( 31 minutes ago )
Domestic shooting kills 3, sparks manhunt in Alabama
Authorities are searching for an armed man after a domestic shooting left three people dead an Alabama mobile home community near Birmingham.
4:23PM ( 42 minutes ago )
AP National News
Latino plaintiffs sue California alleging poor health care
A court challenge says California is harming medical care for more than 13 million lower-income residents _ the majority of them Latinos _ by failing to pay doctors enough to provide proper care
3:22PM ( 1 hour ago )
NYC launches $32 million plan to reduce rat population
New York City announces a $32 million, multi-agency plan to reduce its rat population
3:04PM ( 2 hours ago )
FDA advisers review data on potential 1st US gene therapy
FDA advisers hear details about what could be the first gene therapy approved in the US
2:53PM ( 2 hours ago )
AP Health
A brief look at the medical issues in the Charlie Gard case
A brief look at the medical and legal issues in the case of Charlie Gard, an 11-month-old who has a rare genetic disease
2:06PM ( 2 days ago )
UK court rehears Charlie Gard case in light of new evidence
A British court has given the parents of 11-month-old Charlie Gard a chance to present fresh evidence that their terminally ill son should receive experimental treatment
11:38AM ( 2 days ago )
Charlie Gard case heads to UK court in light of new evidence
A British court will assess new evidence in the case of Charlie Gard as his mother pleaded with judges to allow the terminally ill infant to receive experimental treatment
5:22AM ( 2 days ago )
AP Health - Children's Health
Apple to open data center in China with government ties
Apple will open a data center in mainland China with ties to the country's government in a move likely to raise concerns about the security of iCloud accounts that store personal information transferred from iPhones, iPads and Mac computers there
4:39PM ( 27 minutes ago )
Royal Bank of Scotland in $5.5B settlement over US mortgages
Royal Bank of Scotland has reached a $5.5 billion settlement in the United States over mortgage-backed securities issued before the financial crisis
3:59PM ( 1 hour ago )
Hungary: Government ending disputed anti-Soros ad campaign
The Hungarian government says it will end its disputed ad campaign against Hungarian-American billionaire George Soros
3:56PM ( 1 hour ago )
AP Business
US stocks solidly higher in afternoon trading; oil rises
U.S. stocks are on course for a solidly higher close following a broad market rally
3:22PM ( 1 hour ago )
FBI nominee says Trump-Russia probe is no 'witch hunt'
Breaking with the president, the lawyer Donald Trump picked to lead the FBI declared Wednesday that he does not believe a special counsel investigation into possible coordination between Russia and the Trump presidential campaign is a "witch hunt."
1:17PM ( 3 hours ago )
The Latest: Shell compensates victims of Pakistani oil fire
The Latest: Subsidiary of Royal Dutch Shell says it's made full payments to victims of oil tanker fire that killed 215
12:23PM ( 4 hours ago )
AP Business - Corporate News
The Latest: GOP lawmakers push for expanded audits of Fed
The Latest: GOP lawmakers push for expanded audits of Federal Reserve
1:07PM ( 3 hours ago )
General: Jet was at cruising altitude before problems, crash
As authorities comb through the site of a deadly military plane crash in Mississippi, officials say the KC-130 apparently developed problems while at cruising altitude
12:35PM ( 4 hours ago )
US stocks solidly higher in midday trading; oil rises
U.S. stocks are moving higher in midday trading as investors size up Federal Reserve chair Janet Yellen's remarks before Congress
12:23PM ( 4 hours ago )
AP Business - Industries
Tough question for hospitals: Who's too risky to release?
The case of man who killed a New York City police officer after a psychiatric evaluation highlights how psychiatrists must decide whether patients pose enough danger to need hospitalization
2:56PM ( 4 days ago )
Foreign experts see Chinese Nobel laureate; prognosis grim
The hospital treating China's imprisoned Nobel Peace Prize laureate Liu Xiaobo says American and German specialists have seen Liu and confirmed that he is in the final stages of terminal liver cancer
9:11AM ( 4 days ago )
Foreign experts see China's Nobel laureate; prognosis grim
The hospital treating China's imprisoned Nobel Peace Prize laureate Liu Xiaobo says American and German specialists have seen Liu and confirmed that he is in the final stages of terminal liver cancer
8:32AM ( 4 days ago )
AP Business - Health Care
Where's Rey? Despite Monopoly maker's promise, still missing
The Rey character from the "Star Wars" version of Monopoly apparently is in a land far, far away
4:57PM ( 9 minutes ago )
Brittany Lang needs better to defend in US Women's Open
The U.S. Women's Open has not had a repeat winner since Karrie Webb in 2001 and the chances of Brittany Lang doing it this year don't seem good
4:57PM ( 9 minutes ago )
French court annuls Google's $1.27 billion back tax bill
A French court annulled Wednesday a 1.1 billion-euro ($1.27 billion) tax adjustment imposed on Google by France's tax authorities, saying the way the California firm operates in the country allows it to be exempt from most taxes
4:50PM ( 15 minutes ago )
DA: Man held on $5M cash bail amid search for 4 missing men
A 20-year-old linked to a Pennsylvania farm at the center of a search for four missing men was arrested on charges he tried to sell one man's car after he went missing, authorities said in announcing the first big break in the case
4:50PM ( 16 minutes ago )
Mayweather has history of tax woes; $7M from 2010 unresolved
Floyd Mayweather Jr. has told the IRS he doesn't have enough cash to pay his back taxes before his highly anticipated fight against Conor McGregor next month
4:43PM ( 23 minutes ago )